These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26316040)

  • 41. Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma.
    Sok V; Marzan F; Gingrich D; Aweeka F; Huang L
    PLoS One; 2021; 16(3):e0247356. PubMed ID: 33667247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy.
    Petri M; Elkhalifa M; Li J; Magder LS; Goldman DW
    Arthritis Rheumatol; 2020 Mar; 72(3):448-453. PubMed ID: 31532077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Could Cytochrome P450 2D6, 3A4 and 3A5 Polymorphisms Explain the Variability in Clinical Response to Clomiphene Citrate of Anovulatory PCOS Women?
    Robin C; Hennart B; Broly F; Gruchala P; Robin G; Catteau-Jonard S
    Front Endocrinol (Lausanne); 2021; 12():718917. PubMed ID: 34690927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus.
    Fasano S; Messiniti V; Iudici M; Coscia MA; Ciccia F
    Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36631164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine.
    Sakai R; Honda S; Tanaka E; Majima M; Konda N; Takada H; Harigai M
    Lupus; 2020 Nov; 29(13):1712-1718. PubMed ID: 32838624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
    Hosokawa Y; Oiwa H
    Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus.
    Yoshida M; Minowa K; Amano H; Asai Y; Yamaji K; Tamura N
    Lupus; 2021 Aug; 30(9):1378-1384. PubMed ID: 33966540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
    Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
    Intern Med; 2019 May; 58(9):1257-1262. PubMed ID: 30626831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of hydroxychloroquine in Japanese systemic lupus erythematosus patients with renal impairment.
    Shimizu M; Furudate S; Nagai Y; Shimada K; Ohshima M; Setoguchi K; Hashiguchi M; Yokogawa N
    Mod Rheumatol; 2023 Aug; 33(5):953-960. PubMed ID: 36112484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus.
    Ting TV; Kudalkar D; Nelson S; Cortina S; Pendl J; Budhani S; Neville J; Taylor J; Huggins J; Drotar D; Brunner HI
    J Rheumatol; 2012 Jan; 39(1):174-9. PubMed ID: 22089460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.
    Kim KA; Park IB; Park JY
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1281-1289. PubMed ID: 29947950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
    Takamasu E; Yokogawa N; Shimada K; Sugii S
    Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    Yang J; Yang X; Yang J; Li M
    J Rheumatol; 2018 Jun; 45(6):818-826. PubMed ID: 29545450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
    Miyagawa I; Nakano K; Nakayamada S; Iwata S; Hanami K; Fukuyo S; Kubo S; Kawabe A; Miyazaki Y; Inoue Y; Ueno M; Ohkubo N; Fujita Y; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):549-558. PubMed ID: 32020727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
    Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Hammoud HA; Aymard G; Cacoub P; Francès C; Wechsler B; Huong du LT; Ghillani P; Musset L; Lechat P; Piette JC
    Arthritis Rheum; 2006 Oct; 54(10):3284-90. PubMed ID: 17009263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
    Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
    JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
    Lang MG; Vinagre CG; Bonfa E; Freitas FR; Pasoto SG; Brito TS; Seguro LP; Maranhão RC; Borba EF
    Lupus; 2022 May; 31(6):659-665. PubMed ID: 35332823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.